Skip to main content
Erschienen in: European Journal of Applied Physiology 2/2009

01.01.2009 | Original Article

Salbutamol intake and substrate oxidation during submaximal exercise

verfasst von: A. Arlettaz, B. Le Panse, H. Portier, A.-M. Lecoq, R. Thomasson, J. De Ceaurriz, K. Collomp

Erschienen in: European Journal of Applied Physiology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

In order to test the hypothesis that salbutamol would change substrate oxidation during submaximal exercise, eight recreationally trained men twice performed 1 h at 60% VO2 peak after ingestion of placebo or 4 mg of salbutamol. Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, insulin, and blood glucose and lactate determination. With salbutamol versus placebo, there was no significant difference in total energy expenditure and substrate oxidation, but the substrate oxidation balance was significantly modified after 40 min of exercise. ACTH was significantly decreased with salbutamol during the last 10 min of exercise, whereas no difference was found between the two treatments in the other hormonal and metabolic parameters. The theory that the ergogenic effect of salbutamol results from a change in substrate oxidation has little support during relatively short term endurance exercise, but it is conceivable that longer exercise duration can generate positive findings.
Literatur
Zurück zum Zitat Al-Damluji S, Perry L, Tomlin S, Bouloux P, Grossman A, Rees LH, Besser GM (1987) Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 45:68–76PubMedCrossRef Al-Damluji S, Perry L, Tomlin S, Bouloux P, Grossman A, Rees LH, Besser GM (1987) Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 45:68–76PubMedCrossRef
Zurück zum Zitat Arlettaz A, Portier H, Lecoq A-M, Labsy Z, De Ceaurriz J, Collomp K (2008) Effects of acute prednisolone intake on substrate utilization during submaximal exercise. Int J Sports Med 29:21–26PubMedCrossRef Arlettaz A, Portier H, Lecoq A-M, Labsy Z, De Ceaurriz J, Collomp K (2008) Effects of acute prednisolone intake on substrate utilization during submaximal exercise. Int J Sports Med 29:21–26PubMedCrossRef
Zurück zum Zitat Carter SL, Rennie C, Tarnopolsky MA (2001) Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab 280:E898–E907PubMed Carter SL, Rennie C, Tarnopolsky MA (2001) Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab 280:E898–E907PubMed
Zurück zum Zitat Collomp K, Candau R, Collomp R, Carra J, Lasne F, Préfaut C, De Ceaurriz J (2000a) Effects of acute ingestion of salbutamol during submaximal exercise. Int J Sports Med 21:480–484PubMedCrossRef Collomp K, Candau R, Collomp R, Carra J, Lasne F, Préfaut C, De Ceaurriz J (2000a) Effects of acute ingestion of salbutamol during submaximal exercise. Int J Sports Med 21:480–484PubMedCrossRef
Zurück zum Zitat Collomp K, Candau R, Lasne F, Labsy Z, Ch Préfaut, De Ceaurriz J (2000b) Effects of short-term oral salbutamol administration on exercise endurance and metabolism. J Appl Physiol 89:430–436PubMed Collomp K, Candau R, Lasne F, Labsy Z, Ch Préfaut, De Ceaurriz J (2000b) Effects of short-term oral salbutamol administration on exercise endurance and metabolism. J Appl Physiol 89:430–436PubMed
Zurück zum Zitat Collomp K, Candau R, Millet G, Mucci P, Borrani F, Préfaut C, De Ceaurriz J (2002) Effects of salbutamol and caffeine ingestion on exercise metabolism and performance. Int J Sports Med 23:549–554PubMedCrossRef Collomp K, Candau R, Millet G, Mucci P, Borrani F, Préfaut C, De Ceaurriz J (2002) Effects of salbutamol and caffeine ingestion on exercise metabolism and performance. Int J Sports Med 23:549–554PubMedCrossRef
Zurück zum Zitat Collomp K, Le Panse B, Portier H, Lecoq AM, Jaffre C, Richard O, Benhamou L, Courteix D, De Ceaurriz J (2005) Effects of acute salbutamol intake during a Wingate test. Int J Sports Med 26:513–517PubMedCrossRef Collomp K, Le Panse B, Portier H, Lecoq AM, Jaffre C, Richard O, Benhamou L, Courteix D, De Ceaurriz J (2005) Effects of acute salbutamol intake during a Wingate test. Int J Sports Med 26:513–517PubMedCrossRef
Zurück zum Zitat Giustina A, Malerba M, Bresciani E, Desenzani P, Licini M, Zaltieri G, Grassi V (1995) Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis. J Endocrinol Invest 18:847–852PubMed Giustina A, Malerba M, Bresciani E, Desenzani P, Licini M, Zaltieri G, Grassi V (1995) Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis. J Endocrinol Invest 18:847–852PubMed
Zurück zum Zitat Green HJ, Jones S, Ball-Burnett M, Farrance B, Ranney D (1995) Adaptations in muscle metabolism to prolonged voluntary exercise and training. J Appl Physiol 78:138–145PubMed Green HJ, Jones S, Ball-Burnett M, Farrance B, Ranney D (1995) Adaptations in muscle metabolism to prolonged voluntary exercise and training. J Appl Physiol 78:138–145PubMed
Zurück zum Zitat Hoeks J, Van Baak M, Hesselink M, Hul G, Vidal H, Saris W, Schrauwen P (2003) Effect of β1- and β2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. Am J Physiol Endocrinol Metab 285:E775–E782PubMed Hoeks J, Van Baak M, Hesselink M, Hul G, Vidal H, Saris W, Schrauwen P (2003) Effect of β1- and β2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. Am J Physiol Endocrinol Metab 285:E775–E782PubMed
Zurück zum Zitat Le Panse B, Collomp K, Portier H, Lecoq AM, Jaffre C, Beaupied H, Richard O, Benhamou L, De Ceaurriz J, Courteix D (2005) Effects of short-term salbutamol ingestion during a Wingate test. Int J Sports Med 26:518–523PubMedCrossRef Le Panse B, Collomp K, Portier H, Lecoq AM, Jaffre C, Beaupied H, Richard O, Benhamou L, De Ceaurriz J, Courteix D (2005) Effects of short-term salbutamol ingestion during a Wingate test. Int J Sports Med 26:518–523PubMedCrossRef
Zurück zum Zitat Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K (2006) Short term salbutamol ingestion and supramaximal exercise in healthy women. Br J Sports Med 40:627–631PubMedCrossRef Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K (2006) Short term salbutamol ingestion and supramaximal exercise in healthy women. Br J Sports Med 40:627–631PubMedCrossRef
Zurück zum Zitat Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K (2007) Effects of acute salbutamol intake during supramaximal exercise in women. Br J Sports Med 41:430–434PubMedCrossRef Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K (2007) Effects of acute salbutamol intake during supramaximal exercise in women. Br J Sports Med 41:430–434PubMedCrossRef
Zurück zum Zitat Perronet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16:23–29 Perronet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16:23–29
Zurück zum Zitat Rolf Smith S, Kendall M (1984) Metabolic responses to β2 stimulants. J R Coll Chest Physiol 18:190–194 Rolf Smith S, Kendall M (1984) Metabolic responses to β2 stimulants. J R Coll Chest Physiol 18:190–194
Zurück zum Zitat Schiffelers S, Brouwer E, Saris W, Van Baak M (1998) Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man. Metabolism 47:1462–1467PubMedCrossRef Schiffelers S, Brouwer E, Saris W, Van Baak M (1998) Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man. Metabolism 47:1462–1467PubMedCrossRef
Zurück zum Zitat Schiffelers S, Saris W, Boomsma F, Van Baak M (2001) Beta(1)- and beta(2)-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J Clin Endocrinol Metab 86:2191–2199PubMedCrossRef Schiffelers S, Saris W, Boomsma F, Van Baak M (2001) Beta(1)- and beta(2)-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J Clin Endocrinol Metab 86:2191–2199PubMedCrossRef
Zurück zum Zitat Schiffelers S, Van Harmelen V, De Grauw H, Saris W, Van Baak M (1999) Dobutamine as selective β1-adrenoceptor agonist in in vivo studies on human thermogenesis and lipid utilization. J Appl Physiol 87:977–981PubMed Schiffelers S, Van Harmelen V, De Grauw H, Saris W, Van Baak M (1999) Dobutamine as selective β1-adrenoceptor agonist in in vivo studies on human thermogenesis and lipid utilization. J Appl Physiol 87:977–981PubMed
Zurück zum Zitat Stisen A, Stougaard O, Langfort J, Helge J, Sahlin K, Madsen K (2006) Maximal fat oxidation rates in endurance trained and untrained women. Eur J Appl Physiol 98:497–506PubMedCrossRef Stisen A, Stougaard O, Langfort J, Helge J, Sahlin K, Madsen K (2006) Maximal fat oxidation rates in endurance trained and untrained women. Eur J Appl Physiol 98:497–506PubMedCrossRef
Zurück zum Zitat Van Baak M, Mayer L, Kempinski R, Hartgens F (2000) Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc 32:1300–1306PubMedCrossRef Van Baak M, Mayer L, Kempinski R, Hartgens F (2000) Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc 32:1300–1306PubMedCrossRef
Zurück zum Zitat Van Baak M, de Hon O, Hartgens F, Kuipers H (2004) Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. Int J Sports Med 25:533–538PubMedCrossRef Van Baak M, de Hon O, Hartgens F, Kuipers H (2004) Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. Int J Sports Med 25:533–538PubMedCrossRef
Zurück zum Zitat Wager J, Fredholm B, Lunell N, Persson B (1982) Metabolic and circulatory effects of intravenous and oral salbutamol in late pregnancy in diabetic and non-diabetic women. Acta Obstet Gynecol Scand Suppl 108:41–46PubMedCrossRef Wager J, Fredholm B, Lunell N, Persson B (1982) Metabolic and circulatory effects of intravenous and oral salbutamol in late pregnancy in diabetic and non-diabetic women. Acta Obstet Gynecol Scand Suppl 108:41–46PubMedCrossRef
Zurück zum Zitat Werle E, Strobel G, Weicker H (1990) Decrease in rat cardiac beta1- and beta2-adrenoceptors by training and endurance exercise. Life Sci 46:9–17PubMedCrossRef Werle E, Strobel G, Weicker H (1990) Decrease in rat cardiac beta1- and beta2-adrenoceptors by training and endurance exercise. Life Sci 46:9–17PubMedCrossRef
Metadaten
Titel
Salbutamol intake and substrate oxidation during submaximal exercise
verfasst von
A. Arlettaz
B. Le Panse
H. Portier
A.-M. Lecoq
R. Thomasson
J. De Ceaurriz
K. Collomp
Publikationsdatum
01.01.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Applied Physiology / Ausgabe 2/2009
Print ISSN: 1439-6319
Elektronische ISSN: 1439-6327
DOI
https://doi.org/10.1007/s00421-008-0891-7

Weitere Artikel der Ausgabe 2/2009

European Journal of Applied Physiology 2/2009 Zur Ausgabe

Neu im Fachgebiet Arbeitsmedizin

Das Geschlechterparadoxon in der gesundheitlich beeinträchtigten Lebenszeit – Ende eines Mythos?

Beginnend mit den 1920er-Jahren hat sich eine Vorstellung über die Geschlechterdifferenzen in Gesundheit und Mortalität etabliert, die von Lorber und Moore in dem einprägsamen Satz: „Women get sicker, but men die quicker“, zusammengefasst wurde [ 1 …, S. 13]. Tatsächlich erscheinen vor dem Hintergrund der höheren Lebenserwartung der Frauen die Studienergebnisse zu den Geschlechterdifferenzen in der Morbidität überraschend, wonach Frauen im Durchschnitt einen schlechteren Gesundheitszustand aufweisen als Männer [

Gesunde Lebenserwartung: Ein kritischer Blick auf Nutzen und Potenziale des demographischen Gesundheitsindikators

Open Access Leitthema

Die demographische Alterung hat vielfältige gesellschaftliche Konsequenzen, deren Ausmaß wesentlich vom Gesundheitszustand der Bevölkerung abhängt. Um diesen analysieren und bewerten zu können, wurden spezielle Kennziffern entwickelt, die in …

Wie hat sich die Lebenserwartung ohne funktionelle Einschränkungen in Deutschland entwickelt? Eine Analyse mit Daten des Deutschen Alterssurveys (DEAS)

Deutschland erfährt, wie andere Hocheinkommensstaaten, aufgrund kontinuierlich rückläufiger Mortalität und niedriger Geburtenraten tiefgreifende demografische Veränderungen. Der demografische Wandel führt in Deutschland zu einem zunehmend höheren …

Hitzeschutz im Fokus der hessischen Betreuungs- und Pflegeaufsicht

Open Access Klimawandel Übersichtsartikel

Im Sommer 2023 kündigte das Bundesministerium für Gesundheit (BMG) einen nationalen Hitzeschutzplan an und forderte die Länder auf, zu prüfen, „ob die Warnstufen des [Deutschen Wetterdienstes] DWD mit der Durchführung von Akutmaßnahmen …